Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients
about
Surgery for Non-Hodgkin's LymphomaRecognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic reviewThe Comparative Diagnostic Features of Canine and Human Lymphoma.CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases.New insights into monoclonal B-cell lymphocytosis.Fludarabine-containing chemotherapy for patients with previously untreated low-grade non-Hodgkin's lymphoma.Radiotherapy in marginal zone lymphoma.Pediatric nodal marginal zone lymphoma may develop in the adult population.Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.Clinical characteristics and outcome in dogs with splenic marginal zone lymphomaInduction of tolerance to immunogenic tumor antigens associated with lymphomagenesis in HOX11 transgenic mice.A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms.Quadri-lineage disease involving nodal B-cell marginal zone lymphoma, high-grade B-cell lymphoma, Kaposi's syndrome, and acute myeloid leukemia.Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib.A Case of Synchronous Bone Marrow Chronic Myelomonocytic Leukemia (CMML) and Nodal Marginal Zone Lymphoma (NMZL)
P2860
Q26771421-8D215B14-7245-46D8-80EE-2D394B6C5F35Q26996650-8613E83F-C5A9-4C15-B1D0-188E10071913Q30401307-F7DBD46A-88FF-4BC3-9B5F-E0CE086B1E1BQ33800449-57F04524-D851-4AB2-A694-A01C0E246717Q33951481-22B4A123-8F7C-43FB-ACDC-FB250C6347F9Q34256898-C694D674-C359-49D1-93B0-4FCCB1A012EBQ35524728-8E49AFD4-F6ED-4FEA-B255-C97BD4A53DE8Q36578737-26EB44FF-89F0-409F-BEF3-59DDC06A2FAFQ36610861-C920E99B-58E2-4DAF-B342-3BE9E42A4870Q36630461-A2B3723D-0948-4B19-B9DA-96035AA2C631Q36768594-75450E8A-0252-4703-8243-551F2808B391Q37234343-1B1CB3A8-11F4-4E0F-99A0-258E00720AE8Q37291942-6D2CA991-A82E-46C8-BBEB-0B779E8CE54FQ37364653-51B41D8C-AC72-420B-8062-4091BBAC5B46Q41491139-98649E70-17B9-4250-A954-334C94546459Q42881730-391D4851-C683-44EF-A327-732B7727C8F6Q52599792-1F2D8BDA-945A-4766-9E38-CF4E594CAC5FQ58693769-B9728B25-A7C3-4AEE-908D-350533D7EBEA
P2860
Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Non-MALT marginal zone B-cell ...... on and outcome in 124 patients
@ast
Non-MALT marginal zone B-cell ...... on and outcome in 124 patients
@en
Non-MALT marginal zone B-cell ...... on and outcome in 124 patients
@nl
type
label
Non-MALT marginal zone B-cell ...... on and outcome in 124 patients
@ast
Non-MALT marginal zone B-cell ...... on and outcome in 124 patients
@en
Non-MALT marginal zone B-cell ...... on and outcome in 124 patients
@nl
prefLabel
Non-MALT marginal zone B-cell ...... on and outcome in 124 patients
@ast
Non-MALT marginal zone B-cell ...... on and outcome in 124 patients
@en
Non-MALT marginal zone B-cell ...... on and outcome in 124 patients
@nl
P2093
P1433
P1476
Non-MALT marginal zone B-cell ...... on and outcome in 124 patients
@en
P2093
Baseggio L
Callet-Bauchu E
Coiffier B
Thieblemont C
P304
P407
P577
2000-03-01T00:00:00Z